CompletedNCT04498754
Official study titleAn Evaluation of Insomnia Treatment to Reduce Cardiovascular Risk in Patients With Posttraumatic Stress Disorder
This study has finished and is no longer accepting participants.
In DurhamPTSDBehavioural studyAges 40–59
- Countries
- United States
- Sponsor
- Duke University
Active Not RecruitingACTRN12616000248460
This study is no longer accepting new participants.
In AustraliaAnxietyInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Curtin University
CompletedNCT01852357
About this title
An Evaluation of Neurofeedback Efficacy in Adults With ADHD
Read the official source — NCT01852357Official study titleA Placebo-Control Evaluation of Neurofeedback Efficacy in Adults With ADHD
This study has finished and is no longer accepting participants.
In WilmingtonADHDInterventional studyAges 18–40
- Countries
- United States
- Sponsor
- University of North Carolina, Wilmington
TerminatedACTRN12614000907640
Official study titleDo adolescents with major depressive disorder (MDD) who receive left-sided, high frequency transcranial magnetic stimulation (TMS) experience reduction in depressive symptoms more than those adolescents with MDD who are given right sided TMS.
This study ended early.
Multiple locations, including DandenongDepression, AnxietyInterventional studyAges 13–18
- Countries
- Australia
- Sponsor
- Monash Health
CompletedACTRN12612000351819
Official study titleA Randomised Controlled Trial of Standard Care versus Stepped Care for Children and Adolescents with Anxiety Disorders
This study has finished and is no longer accepting participants.
In AustraliaAnxietyInterventional studyAges 7–17
- Countries
- Australia
- Sponsor
- Macquarie University
CompletedNCT06247930
Official study titleEffect of Vitamin D Supplementation on Depressive Symptoms in Chinese Early Adolescents
This study has finished and is no longer accepting participants.
In AnqingDepressionBehavioural studyAges 10–15
- Countries
- China
- Sponsor
- Anhui Medical University
Active Not RecruitingACTRN12618001722280
This study is no longer accepting new participants.
In AustraliaAddictionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Lives Lived Well
CompletedACTRN12615000791538
Official study titleAn evaluation of the efficacy of curcumin and saffron for the treatment of depression: a randomised, double-blind, placebo controlled-trial
This study has finished and is no longer accepting participants.
In AustraliaDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Murdoch University
CompletedNCT06237426
What is this study about?Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.
This study has finished and is no longer accepting participants.
Multiple locations, including DenverPTSDMedication studyAges 18–71
- Countries
- United States, United Kingdom, Ireland
- Sponsor
- Transcend Therapeutics
Enrolling By InvitationNCT07670702
What is this study about?Researchers are studying TSND-201 to find out how it affects post-traumatic stress symptoms in people with PTSD.
This study is by invitation only.
Multiple locations, including Little RockPTSDMedication study
- Countries
- United States
- Sponsor
- Transcend Therapeutics
CompletedACTRN12613000216718
Official study titleA quasi-experimental waiting list controlled trial of cognitive behaviour therapy in mentally disordered offenders: the impact on completion, attitudes towards violence, anger, coping processes, social problem solving, and ward behaviour (disruptive behaviour and social problems).
This study has finished and is no longer accepting participants.
In United KingdomPersonality disorders, SchizophreniaInterventional studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- Broadmoor Hospital
TerminatedNCT00412620
What is this study about?Researchers are comparing ABT-925 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–65
- Countries
- United States, Argentina, Mexico
- Sponsor
- Abbott